Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025)
Alphatec Holdings' (ATEC) quarterly Non-Current Deffered Revenue came in at $2.2 million in Q4 2025, down 29.68% year-on-year from $3.1 million in Q4 2024, and down 29.68% quarter-over-quarter from $3.1 million in Q4 2024.
Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends
Alphatec Holdings has disclosed Non-Current Deffered Revenue across 5 years of filings, most recently posting $2.2 million for Q4 2025.
- Non-Current Deffered Revenue for Q4 2025 came in at $2.2 million, down 29.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.2 million (down 29.68% YoY), and the FY2025 annual result was $2.2 million, down 29.68% from the prior year.
- Non-Current Deffered Revenue came in at $2.2 million for Q4 2025 at Alphatec Holdings, down from $3.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $3.1 million in Q4 2024 to a low of $2.2 million in Q4 2025.
- The 5-year median for Non-Current Deffered Revenue is $2.8 million (2021), against an average of $2.8 million.
- Across the five-year window, Non-Current Deffered Revenue rose 19.23% in 2024 and retreated 29.68% in 2025, its largest moves.
- Alphatec Holdings' Non-Current Deffered Revenue stood at $2.9 million in 2021, then gained by 5.18% to $3.0 million in 2022, then declined by 14.67% to $2.6 million in 2023, then advanced by 19.23% to $3.1 million in 2024, then declined by 29.68% to $2.2 million in 2025.
- The last three Non-Current Deffered Revenue figures came in at $2.2 million (Q4 2025), $3.1 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Alphatec Holdings | 1.34 Bn | 1.20 Bn | 136.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 2.71 Mn |